The inhibitory effects of rosmarinic acid on catabolism induced by IL-1β in rat chondrocyte

Zhong-Nan Hu; Li-Juan Huang; Wei-Ping Chen

doi:10.18388/abp.2018_2607

Zhong-Nan Hu Department of Orthopedics Surgery, The Children’s Hospital of Medical College, Zhejiang University, Hangzhou, People's Republic of China.
Li-Juan Huang Hemodialysis center, Division of Nursing, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China
Wei-Ping Chen Department of Orthopedics Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China

DOI: https://doi.org/10.18388/abp.2018_2607

Abstract

The effects of rosmarinic acid (RosA) on osteoarthritis (OA) was investigated in rat chondrocytes. Chondrocytes were isolated from rat cartilage, incubated with RosA in the presence of interleukin-1beta (IL-1β) (10 ng/ml). The production of IL-6, as well as the mRNA level of aggrecan (ACAN) and collagen 2 (COL2), were assessed. The gene and protein expression of A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-4, ADAMTS-5 were also measured. RosA inhibited the production of IL-6 as well as the gene and protein expression of ADAMTS-4 and ADAMTS-5, in addition, RosA abolished IL-1β-induced inhibition of ACAN and COL2 gene expression. Our results suggest that RosA can inhibit extracellular matrix (ECM) degradation in OA, thus, RosA may be a possible agent in the treatment of OA.

References

Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, Ellis DM,Tortorella MD, Pratta MA, Hollis JM et al (1999) Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274:23443-23450.

Apte SS(2016) Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis. Biochem J 473:e1-4.

Berenbaum F(2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage21:16-21.

Cao W, Hu C, Wu L, Xu L, Jiang W(2016) Rosmarinic acid inhibits inflammation and angiogenesis of hepatocellular carcinoma by suppression of NF-κB signaling in H22 tumor-bearing mice. J Pharmacol Sci 132:131-137.

Connelly AE, Tucker AJ, Tulk H, Catapang M, Chapman L, Sheikh N, Yurchenko S, Fletcher R, Kott LS, Duncan AM, Wright AJ(2014) High-rosmarinic acid spearmint tea in the management of knee osteoarthritis symptoms. J Med Food 17:1361-1367.

Daheshia M, Yao JQ(2008) The interleukin 1beta pathway in the pathogenesis of osteoarthritis.J Rheumatol 35:2306-23012.

Gendron C, Kashiwagi M, Lim NH, Enghild JJ, Thøgersen IB, Hughes C, Caterson B, Nagase H(2007) Proteolytic activities of human ADAMTS-5:Comparative studies with ADAMTS-4. J Biol Chem 282:18294-18306.

Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ(2015) Osteoarthritis. Lancet 386: 376-387.

Jin BR, Chung KS, Cheon SY, Lee M, Hwang S, Noh Hwang S, Rhee KJ, An HJ(2017) Rosmarinic acid suppresses colonic inflammation in dextran sulphate sodium (DSS)-induced mice via dual inhibition of NF-κB and STAT3 activation. Sci Rep 7:46252.

Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, Brockbank SMV, Edwards DR, Parker AE, Clark IM (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50:131-141.

Koshy PJT, Lundy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM, Cawston TE(2002) The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: A time-course study using real-time quantitative reverse transcriptionpolymerase chain reaction. Arthritis Rheum 46:961-967.

Martel-Pelletier J, Welsch DJ, Pelletier JP (2001) Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 15:805-829.

Mankin HJ, Lippiello L(1970) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg Am 52:424-434.

Neogi T(2013) The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage 21:1145-1153.

Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, Sokolove J (2016) Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol 12:580-592.

Scanzello CR(2017) Chemokines and inflammation in osteoarthritis: Insights from patients and animal models. J Orthop Res35:735-739.

Tonge DP, Pearson MJ, Jones SW (2014) The hallmarks of osteoarthritis and the potential to develop personalised diseasemodifying pharmacological the

rapeutics. Osteoarthritis Cartilage 22:609-621.

Tortorella MD, Malfait AM, Deccico C, Arner E(2001) The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 9:539-552.

Troeberg L,Nagase H(2012) Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta 1824: 133-145.

Verma P, Dalal K (2011) ADAMTS-4 and ADAM TS-5: Key Enzymes in Osteoarthritis. Journal of Cellular Biochemistry112:3507-3514.

Verma P, Dalal K, Chopra M(2016) Pharmacophore development and screening for discovery of potential inhibitors of ADAMTS-4 for osteoarthritis therapy. J Mol Model 22:178.

Wu CF, Hong C, Klauck SM, Lin YL, Efferth T(2015) Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells. J Ethnopharmacol 176:55-68.

Yang CY, Chanalaris A, Troeberg L(2017) ADAMTS and ADAM metalloproteinases in osteoarthritis-looking beyond the 'usual suspects'. Osteoarthritis Cartilage 25:1000-1009.